Search Results

Important Considerations in the Biology of Postthrombotic Syndrome

Biomarkers, research, and new horizons in the treatment of this serious disease.

By Peter Henke, MD

The Best Answers Come From the Hardest Questions . . . So Keep Asking ‘Em

By Suresh Vedantham, MD

Five Must-Read Superficial Venous Publications

By Peter F. Lawrence, MD

Lung Ablation

Panelists: Kamran Ahrar, MD, MBA; Sharjeel H. Sabir, MD; Alda L. Tam, MD; Robert Suh, MD; Peter J. Littrup, MD; and Damian E. Dupuy, MD, FACR

Meeting the Challenge

By Barry T. Katzen, MD, Chief Medical Editor

SFA: A Closer Look

By John R. Laird, MD

Updating Our Understanding of EVAR

Have the results shown a significant improvement in outcomes with a new generation of devices?

By Frederico Bastos Gonçalves, MD; Sander ten Raa, MD, PhD; Daniël Eefting, MD, PhD; Ellen V. Rouwet, MD, PhD; Johanna M. Hendriks, MD, PhD; and Hence J. M. Verhagen, MD, PhD

Nine Months Later… An Interview With Konstantinos Katsanos, MD

Dr. Katsanos's thoughts regarding the vascular community's reaction to his group's meta-analysis, the potential influence of follow-up and adjudication variables, non-SFA applications, and what comes next.

With Konstantinos Katsanos, MSc, MD, PhD, EBIR

Expert Roundtable

Featuring Anthony J. Comerota, MD; Marc H. Glickman, MD, FACS; Thomas A. Hennebry, MB BCh BAO, FACC, FSCAI; Charles Pollack, MD, MA; and Mahmood K. Razavi, MD